Neurontin Plaintiffs Make Bid For Class Certification
Plaintiffs are seeking to obtain class status in a multidistrict litigation accusing Pfizer Inc. and its Warner-Lambert Co. subsidiary of using patent litigation to postpone generic competition for epilepsy treatment Neurontin....To view the full article, register now.
Already a subscriber? Click here to view full article